Physician profile
Jaytinder S Sandhu
NPI 1629376264
$17,393.24
in general payments reported to CMS, 2019-2025
28 companies · $1,092 in 2025
The $1,092 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,254 · 2020: $3,221 · 2021: $1,560 · 2022: $2,941 · 2023: $2,157 · 2024: $4,168 · 2025: $1,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,650 · Royalty Or License: $2,262 · Travel and Lodging: $1,291 · Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,650.00 |
| Royalty Or License | $2,262.40 |
| Travel and Lodging | $1,291.33 |
| Food and Beverage | $1,212.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nvision Biomedical Technologies, INC. | $5,248.66 | 2021-2024 | Vector |
| Tenex Health INC. | $4,133.79 | 2019-2020 | |
| Ortho Solutions INC | $2,191.00 | 2023-2024 | |
| Pylant Medical | $1,865.00 | 2019-2022 | |
| Medical Device Business Services, INC. | $812.51 | 2025 | Na |
| Bone Support INC. | $774.67 | 2023-2024 | Ceramentbone Void Filler, Cerament G |
| Musculoskeletal Transplant Foundation INC. | $399.79 | 2023 | |
| Stryker Corporation | $397.74 | 2019-2024 | Hoffmann, Ortholoc 3di, Augment Injectable |
| Paragon 28, INC. | $346.93 | 2024 | Apex 3d |
| Orthofix Medical, INC. | $260.85 | 2020-2025 | Truelok, Physio-Stim |
| Kerecis Limited | $142.85 | 2019 | |
| Depuy Synthes Sales INC. | $138.47 | 2019-2024 | Na, Monovisc, Orthovisc |
| Horizon Therapeutics Plc | $127.78 | 2019-2020 | |
| Melinta Therapeutics, LLC | $120.52 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $89.95 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $73.60 | 2022 | |
| Grt US Holding, INC. | $44.70 | 2022 | |
| Molnlycke Health Care US, LLC | $28.20 | 2024 | Exufiber Ag+, Avance, Mepilex Border Post-Op Ag |
| Vertex Pharmaceuticals Incorporated | $24.53 | 2025 | |
| Pacira Therapeutics, INC. | $24.43 | 2019 | |
| Ossur Americas, INC. | $23.44 | 2025 | |
| Smith+Nephew, INC. | $21.89 | 2023 | Pico 7 |
| Tactile Systems Technology INC | $18.24 | 2023 | Entre Plus, Flexitouch Plus |
| Zimmer Biomet Holdings, INC. | $17.92 | 2024 | Gps III Platelet Concentration System |
| Boston Scientific Corporation | $17.59 | 2024 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $17.47 | 2023 | |
| Electronic Waveform Lab, INC. | $17.37 | 2023-2024 | |
| Mimedx Group, INC. | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaytinder Sandhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.